SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-051228
Filing Date
2024-04-24
Accepted
2024-04-24 16:16:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2412467d2_defa14a.htm DEFA14A 12787
2 GRAPHIC tm2412467d2_defa14aimg001.jpg GRAPHIC 393363
3 GRAPHIC tm2412467d2_defa14aimg002.jpg GRAPHIC 119299
  Complete submission text file 0001104659-24-051228.txt   720278
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41740 | Film No.: 24870788
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)